Immune rejection drug shrinks rare tumors
BOSTON (Reuters) - The Wyeth drug Rapamune dramatically reduces rare growths known as angiomyolipomas after one year of treatment, but the benefits begin to fade if the transplant drug is discontinued, researchers reported on Wednesday. (Source: Reuters: Health)
Cadence Pharma recalls one lot of Ofirmev
(Reuters) - Cadence Pharmaceuticals Inc said it recalled one lot of its injectable painkiller Ofirmev after a routine stability test revealed the presence of an unidentified particle in a vial. (Source: Reuters: Health)
